PALCICLIB 125 (Palbociclib (125mg))

PALCICLIB 125 Capsule is prescribed for individuals diagnosed with specific forms of breast cancer that are estrogen receptor-positive and human epidermal growth factor receptor 2-negative, which have metastasized to other areas of the body. This medication is often administered in conjunction with hormonal anticancer treatments to enhance its effectiveness. It is important to take PALCICLIB 125 Capsule with food, and maintaining a consistent schedule of administration daily can optimize its therapeutic benefits. The prescribing physician will determine the appropriate dosage based on the patient’s condition and may adjust it as necessary over time. Adhering strictly to the doctor’s instructions is crucial, as incorrect usage or excessive dosing can lead to severe adverse reactions. Although some patients may not notice immediate improvements, it is crucial not to discontinue the medication without consulting a healthcare professional. Notably, this drug may lead to a reduction in blood cells, resulting in a higher risk of infections, hence, should you experience symptoms like fever, chills, or unusual bleeding, it is essential to inform your doctor promptly. Additionally, caution is advised due to possible side effects like dizziness, which can impair activities requiring full attention, such as driving. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.